CRISPR Therapeutics Stock Price

-11.14 (-6.15%)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
CRISPR Therapeutics AG CRSP NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-11.14 -6.15% 170.10 17:06:12
Open Price Low Price High Price Close Price Prev Close
179.09 168.51 183.00 169.53 181.24
Bid Price Ask Price Spread News
169.61 170.00 0.39 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
65,750 2,453,625 $ 174.76 $ 428,801,394 2,450,130 32.00 - 220.21
Last Trade Time Type Quantity Stock Price Currency
17:07:12 32 $ 169.53 USD

CRISPR Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 12.78B 75.13M 66.65M $ 289.59M $ - 0.98 -58.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

CRISPR Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CRSP Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week207.48208.18168.51188.712,184,782-37.38-18.02%
1 Month169.93220.21148.25183.892,649,0710.170.1%
3 Months86.55220.2185.00162.771,860,21083.5596.53%
6 Months91.29220.2176.71135.371,356,63578.8186.33%
1 Year52.50220.2132.00103.661,188,255117.60224.0%
3 Years41.04220.2121.6570.731,018,726129.06314.47%
5 Years15.00220.2111.6366.95778,293155.101,034.0%

CRISPR Therapeutics Description

CRISPR Therapeutics AG is a gene-editing company. It is engaged in the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 is a technology that allows for precise, directed changes to genomic DNA. The company advanced programs target beta-thalassemia and sickle cell disease, two hemoglobinopathies that have a high unmet medical need.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.